JP2023539368A5 - - Google Patents
Info
- Publication number
- JP2023539368A5 JP2023539368A5 JP2023514414A JP2023514414A JP2023539368A5 JP 2023539368 A5 JP2023539368 A5 JP 2023539368A5 JP 2023514414 A JP2023514414 A JP 2023514414A JP 2023514414 A JP2023514414 A JP 2023514414A JP 2023539368 A5 JP2023539368 A5 JP 2023539368A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- seq
- sequence
- nucleic acid
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073843P | 2020-09-02 | 2020-09-02 | |
| US63/073,843 | 2020-09-02 | ||
| PCT/US2021/048267 WO2022051232A1 (en) | 2020-09-02 | 2021-08-30 | Codon optimized rpgrorf 15 genes and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539368A JP2023539368A (ja) | 2023-09-13 |
| JP2023539368A5 true JP2023539368A5 (https=) | 2024-09-06 |
Family
ID=80358240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514414A Pending JP2023539368A (ja) | 2020-09-02 | 2021-08-30 | コドン最適化したｒｐｇｒｏｒｆ１５遺伝子およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20230340042A1 (https=) |
| EP (1) | EP4208156A4 (https=) |
| JP (1) | JP2023539368A (https=) |
| KR (1) | KR102825852B1 (https=) |
| CN (1) | CN116782886A (https=) |
| AU (1) | AU2021337530B2 (https=) |
| BR (1) | BR112023003834A2 (https=) |
| CA (1) | CA3191540A1 (https=) |
| IL (1) | IL300785B2 (https=) |
| WO (1) | WO2022051232A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300785B2 (en) * | 2020-09-02 | 2025-04-01 | 4D Molecular Therapeutics Inc | RPGRORF 15-codon-specific genes and their uses |
| CN117165596A (zh) * | 2022-05-27 | 2023-12-05 | 武汉纽福斯生物科技有限公司 | 编码rpgr的核酸及其应用 |
| EP4696540A1 (en) | 2023-05-11 | 2026-02-18 | LG Energy Solution, Ltd. | Computing system for providing energy management service connected with autonomous driving, operation method of computing system and vehicle |
| CN121693566A (zh) * | 2023-07-28 | 2026-03-17 | 瑞泽恩制药公司 | 使用bGH-SV40L串联PolyA在单向基因插入期间增强转基因表达 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003031569A2 (en) * | 2001-10-10 | 2003-04-17 | Centocor, Inc. | Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid |
| US9163259B2 (en) * | 2012-05-04 | 2015-10-20 | Novartis Ag | Viral vectors for the treatment of retinal dystrophy |
| EP2872183B1 (en) * | 2012-07-11 | 2018-09-26 | The Trustees Of The University Of Pennsylvania | Aav-mediated gene therapy for rpgr x-linked retinal degeneration |
| US9534225B2 (en) * | 2014-04-15 | 2017-01-03 | Applied Genetic Technologies Corporation | Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (RPGR) |
| GB201516066D0 (en) * | 2015-09-10 | 2015-10-28 | Young & Co Llp D | Treatment of retinitis pigmentosa |
| US11364308B2 (en) * | 2016-05-13 | 2022-06-21 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| GB201704192D0 (en) * | 2017-03-16 | 2017-05-03 | Nightstarx Ltd | Treatment of Retinitis Pigmentosa |
| US20210348193A1 (en) | 2018-09-21 | 2021-11-11 | Nightstarx Limited | Compositions and methods for treating retinitis pigmentosa |
| CN113952472A (zh) * | 2020-07-21 | 2022-01-21 | 英斯培瑞有限公司 | 用于治疗眼部疾病的组合物和方法 |
| IL300785B2 (en) * | 2020-09-02 | 2025-04-01 | 4D Molecular Therapeutics Inc | RPGRORF 15-codon-specific genes and their uses |
-
2021
- 2021-08-30 IL IL300785A patent/IL300785B2/en unknown
- 2021-08-30 US US18/042,517 patent/US20230340042A1/en active Pending
- 2021-08-30 AU AU2021337530A patent/AU2021337530B2/en active Active
- 2021-08-30 BR BR112023003834A patent/BR112023003834A2/pt unknown
- 2021-08-30 CA CA3191540A patent/CA3191540A1/en active Pending
- 2021-08-30 EP EP21864959.8A patent/EP4208156A4/en active Pending
- 2021-08-30 CN CN202180072680.6A patent/CN116782886A/zh active Pending
- 2021-08-30 US US17/461,716 patent/US11345930B2/en active Active
- 2021-08-30 WO PCT/US2021/048267 patent/WO2022051232A1/en not_active Ceased
- 2021-08-30 KR KR1020237007137A patent/KR102825852B1/ko active Active
- 2021-08-30 JP JP2023514414A patent/JP2023539368A/ja active Pending
-
2022
- 2022-05-26 US US17/825,665 patent/US20220290181A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023539368A5 (https=) | ||
| JP2021121638A5 (https=) | ||
| JP2022125201A (ja) | 変異体キャプシドを有するアデノ関連ウイルスビリオンおよびその使用方法 | |
| JP2023126919A5 (https=) | ||
| AU2018200657B2 (en) | Methods of predicting ancestral virus sequences and uses thereof | |
| AU2025271096A1 (en) | A modified mGluR6 promoter and methods of use | |
| JP2024519888A5 (https=) | ||
| JP2022530633A5 (https=) | ||
| JP2022530656A5 (https=) | ||
| JP2022544627A5 (https=) | ||
| JP2022106918A5 (https=) | ||
| JP2023504773A5 (https=) | ||
| JP2019502378A5 (https=) | ||
| EP3652326B1 (en) | Means and methods for aav gene therapy in humans | |
| JP2023535956A5 (https=) | ||
| JP2011516049A (ja) | 遺伝子障害を治療する方法 | |
| JP2023539367A5 (https=) | ||
| JP2023528801A5 (https=) | ||
| JP2022522776A5 (https=) | ||
| JP2023513004A5 (https=) | ||
| US20230321220A1 (en) | Aav5-based vaccine against sars-cov-2 | |
| JP7627961B2 (ja) | バルデー・ビードル症候群の遺伝子治療 | |
| Chen | Adeno-associated virus vectors for human gene therapy | |
| JP2022523050A5 (https=) | ||
| CN121693341A (zh) | 药物组合物及其用途 |